Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, July 1999, p. 1700-1703, Vol. 43, No. 7
Departments of Biochemistry and Biological
Sciences, University of Iowa, Iowa City, Iowa 52242
Received 15 March 1999/Returned for modification 21 April
1999/Accepted 10 May 1999
Histidine protein kinases have been explored as potential
antibacterial drug targets. The recent identification of two-component histidine kinases in fungi has led us to investigate the antifungal properties of three bacterial histidine kinase inhibitors (RWJ-49815, RWJ-49968, and RWJ-61907). All three compounds were found to inhibit growth of the Saccharomyces cerevisiae and Candida
albicans strains, with MICs ranging from 1 to 20 µg/ml.
However, deletion of SLN1, the only histidine kinase in
S. cerevisiae, did not alter drug efficacy. In vitro kinase
assays were performed by using the Sln1 histidine kinase purified from
bacteria as a fusion protein to glutathione S-transferase.
RWJ-49815 and RWJ-49968 inhibited kinase a 50% inhibitory
concentration of 10 µM, whereas RWJ-61907 failed to inhibit at
concentrations up to 100 µM. Based on these results, we conclude that
these compounds have antifungal properties; however, their mode of
action appears to be independent of histidine kinase inhibition.
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Antifungal Properties and Target Evaluation of
Three Putative Bacterial Histidine Kinase Inhibitors
*
Corresponding author. Mailing address: Department of
Biochemistry, University of Iowa, Iowa City, IA 52242. Phone: (319)
335-7884. Fax: (319) 335-9570. E-mail:
robert-deschenes{at}uiowa.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»